Literature DB >> 369685

Rubidazone in metastatic breast cancer.

S S Legha, R S Benjamin, A U Buzdar, G N Hortobagyi, G R Blumenschein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 369685

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group study.

Authors:  F E Smith; N Gad-el-Mawla; B Tranum; L H Baker; F J Panettiere; J W Athens; M Foulkes
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

Review 2.  Antitumour antibiotic containing regimens for metastatic breast cancer.

Authors:  S Lord; D Ghersi; M Gattellari; S Wortley; N Wilcken; J Simes
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.